ITMCTR2000003820Not yet recruiting未知
Clinical study on the reversal of indolent B cell lymphoma with fuzheng Huatuanjiedu decoction
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- Male
Inclusion Criteria
- •1. Patients with indolent B-cell lymphoma conforming to the above diagnosis by Traditional Chinese and western medicine do not need to receive western medicine treatment for their condition evaluation;
- •2. Aged 18 and 80 years old;
- •3. Sign informed consent.
Exclusion Criteria
- •1. Patients who meet the diagnostic criteria but are complicated with serious organic diseases such as heart, liver, kidney, brain and other malignant tumors are not eligible for the authors;
- •2. Those who are allergic to the drugs used, have adverse reactions or are in critical condition;
- •3. Participants in other clinical trials at the same time.
Investigators
Similar Trials
Recruiting
Phase 1
Evaluation of the efficacy and safety of Rituximab in patients with Amyotrophic Lateral Sclerosis (ALS)Sporadic Amyotrophic Lateral SclerosisMedDRA version: 21.1Level: PTClassification code: 10002026Term: Amyotrophic lateral sclerosis Class: 100000004852CTIS2022-502743-35-00Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.52
Recruiting
Phase 2
B-cell depletion for the treatment of patients with amyotrophic lateral sclerosis (ALS) - A Randomized, Double-blind, Placebo controlled Pilot Study in Patients with Amyotrophic Lateral Sclerosis for the Evaluation of Efficacy and Safety of B-Cell Depletion with Rituximab (ABCD)G12.2Motor neuron diseaseDRKS00030948Deutsches Zentrum für Neurodegenerative Erkrankungen e.v.65
Not yet recruiting
Phase 2
Comparing Use of B-cell depletion therapy to Immunoglobulin in Chronic inflammatory demyelinating polyneuropathy (CUBIC) clinical trial.Chronic inflammatory demyelinating polyneuropathy (CIDP).Inflammatory and Immune System - Autoimmune diseasesNeurological - Other neurological disordersACTRN12623001336673Western Sydney Local Health District35
Completed
Not Applicable
B-cell differentiation defects and clinical complications in antibody deficiency syndromes with a focus on Common Variable ImmunodeficiencyDisorder of antibody productionhumoral immunodeficiency100214291000381610019815NL-OMON31550Erasmus MC, Universitair Medisch Centrum Rotterdam130
Active, not recruiting
Not Applicable
Estudio de los efectos de la terapia anti-célula B (rituximab) sobre la inmunopatología del tejido sinovial y las células B de sangre periférica en artritis reumatoide (Estudio TESICE-AR).Study of the B-cell-targeted therapy (rituximab) effects on the synovial tissue inmunopathology and peripheral blood B cells in rheumatoid arthritis (TESICE-AR study).Se estudiaran los efectos de la terapia anti-célula B (rituximab) sobre la inmunopatología del tejido sinovial y las células B de sangre periférica en artritis reumatoide.MedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2007-003623-20-ESDr. Juan D. Cañete Crespillo, Hospital Clínic de Barcelona